Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(5 sites)

United States

Emory University Hospital, Atlanta, Georgia

The University of Chicago, Chicago, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Nationwide Children's Hospital, Columbus, Ohio

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania